Life sciences briefing: Friday, Jan. 25, 2008
TODAY’S HEADLINES:
Health-info site HealthCentral Network pulls in $50M (paidContent)
BrightHeart Vet corrals $29M to acquire animal hospitals (release)
AviaraDx raises $8M for cancer diagnostics (peHUB)
Valor Medical aims for $15M for brain-aneurysm treatment (VentureWire)
IPC, inpatient-care provider, raises as much as $56M in IPO (IPO Home)
Phenomix, diabetes and hepatitis… Continue Reading
Life sciences briefing: Wednesday, Dec. 26, 2007
TODAY’S HEADLINES:
Romark Labs raises $18M for hepatitis drugs (release)
Cubist buys Illumigen Bio, a hepatitis-drug biotech, for $9M (release)
MedCap voices opposition to VaxGen-Raven Bio reverse merger (release)
NeuroMetrix acquires EyeTel Imaging assets for $10M (release)
Solstice Neurosciences appoints Dennis Smith as CEO (release)
LeMaitre Vascular snaps up graft maker… Continue Reading
Life sciences briefing: Wednesday, Sept. 26, 2007
Featured companies: Ablynx, Cardiosolutions, Carigent Thereapeutics, Elusys, Genome Corp., GlobeImmune, Novazone, Targanta Therapeutics, Waterfront Media
UPDATED at 5:45am on 9/27/07
GlobeImmune raises $41M for immune-system therapies — GlobeImmune, a Louisville, Colo., biotech focused on new forms of immunotherapy to treat viral infections and cancer, raised $41.2 million in… Continue Reading